A predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival

Fang-Xiao Zhu1, Xiao-Tao Wang2, Hui-Qiong Zeng1

  • 1Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, Guangdong 518040, P.R. China.

Oncology Letters
|October 16, 2019
PubMed

Insights

Autophagy-related genes (ARGs) impact multiple myeloma (MM) progression. A new 16-gene prognostic model accurately predicts patient outcomes and could guide clinical treatment strategies for MM.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Autophagy plays a role in plasma cell development and multiple myeloma (MM) pathogenesis.
  • The prognostic significance of autophagy-related genes (ARGs) in MM is not well-defined.

Purpose of the Study:

  • To investigate the prognostic role of ARGs in MM.
  • To develop a predictive model for MM patient survival based on ARG expression.

Main Methods:

  • Expression profiles of 234 ARGs were analyzed from the GSE24080 dataset (559 MM samples).
  • Univariate and multivariate Cox regression analyses were used to identify survival-associated ARGs.
  • A 16-gene risk score model was constructed and validated in four independent cohorts.

Main Results:

  • 55 ARGs were significantly associated with event-free survival in MM.
  • A 16-gene prognostic signature was developed, effectively stratifying patients into high- and low-risk groups.
  • The model demonstrated good predictive accuracy (AUCs of 0.740, 0.741, and 0.712 for 3, 5, and 10 years, respectively) and was validated across multiple cohorts.

Conclusions:

  • ARGs are crucial in MM progression.
  • The developed ARG-based prognostic model offers potential for clinical application in MM patient management and outcome prediction.